Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.

Health and Human Services Secretary Robert F. Kennedy Jr. has been a vocal critic of drugs like Ozempic which he said cloud the real cause of poor health in the United States.

The Centers for Medicare & Medicaid Services will not cover drugs when exclusively used for weight loss, like Ozempic or Wegovy, the Trump administration announced. The Biden administration previously put forward a rule aimed at reinterpreting a statute that prevented the federal government from covering drugs “when used for weight loss,